Do Human Myeloma Cells Directly Produce the Receptor Activator of Nuclear Factor κB Ligand (RANKL) or Induce RNKL in the Bone Marrow Microenvironment? [1]

Cancer Research

Volumn 64, Issue 2, 2004, Pages 772-773

  Giuliani, Nicola ^a   Colla, Simona ^a   Rizzoli, Vittorio ^a   Barillé Nion, Sophie ^b   Bataille, Régis ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Inst Natl de la Recherche   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

BONE MARROW CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LETTER; MICROENVIRONMENT; MONONUCLEAR CELL; MYELOMA CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

BONE MARROW CELLS; CARRIER PROTEINS; CYTOKINES; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 1642475102     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Farrugia, A. N., Atkins, G. J., To, L. B., Pan, B., Horvath, N., Kostakis, P., Findlay, D. M., Bardy, P., and Zannettino, A. C. Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res., 63: 5438-5445, 2003.
2. Giuliani, N., Bataille, R., Mancini, C., Lazzaretti, M., and Barille, S. Myeloma cells induce imbalance in the osteoprotegerin/ogteoprotegerin ligand system in the human bone marrow environment. Blood, 98: 3527-3533, 2001.
3. Giuliani, N., Colla, S., Sala, R., Moroni, M., Lazzaretti, M., La Monica, S. Bonomini, S., Hojden, M., Sammarelli, G., Barille, S., Bataille, R., and Rizzoli, V. Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood, 100: 4615-4621, 2002.
4. Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., and Choi, Y. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. USA, 98: 11581-11586, 2001.
5. Roux, S., Meignin, V., Quillard, J., Meduri, G., Guiochon-Mantel, A., Fermand, J. P., Milgrom, E., and Mariette, X. RANK (receptor activator of nuclear factor-κB) and RANKL expression in multiple myeloma. Br. J. Haematol., 117: 86-92, 2002.
6. Shaughnessy, J. D., and Barlogie, B. Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling. Immunol. Rev., 194: 140-163, 2003.
7. Zhan, F., Hardin, J., Kordsmeier, B., Bumm, K., Zheng, M., Tian, E., Sanderson, R., Yang, Y., Wilson, C., Zangari, M., Anaissie, E., Morris, C., Muwalla, F., van Rhee, F., Fassas, A., Crowley, J., Tricot, G., Barlogie, B., and Shaughnessy, J., Jr. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood, 99: 1745-1757, 2003.
8. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., and Taniguchi, T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and 1FN-γy. Nature (Lond.), 408: 600-605, 2000.
9. Heider, U., Langelotz, C., Jakob, C., Zavrski, I., Fleissner, C., Eucker, J., Possinger, K., Hofbauer, L. C., and Sezer, O. Expression of receptor activator of nuclear factor KB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. Clin. Cancer. Res., 9: 1436-1440, 2003.
10. Nicholson, G. C., Malakellis, M., Collier, F. M., Cameron, P. U., Holloway, W. R., Gough, T. J., Gregorio-King, C., Kirkland, M. A., and Myers, D. E. Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor κB ligand (RANKL). Clin. Sci. (Lond), 99: 133-140, 2000.
11. Michigami, T., Shimizu, N., Williams, P. J., Niewolna, M., Dallas, S. L., Mundy, G. R., and Yoneda, T. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α(4)β(1)-integrin enhances production of osteoclast-stimulating activity. Blood, 96: 1953-1960, 2000.
12. Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., and Riggs, B. L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone. Miner. Res., 15: 2-12, 2000.